2,428 results match your criteria International journal of technology assessment in health care[Journal]


The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS).

Int J Technol Assess Health Care 2019 Apr 22:1-5. Epub 2019 Apr 22.

Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC).

Earlier activities on health technology assessment (HTA) started in Spain around 1984, with the creation of a National Advisory Board on HTA, and the development of national and regional HTA organizations in the early 1990s. In 2012, the Spanish Health Ministry established the Spanish Network for Health Technology Assessment of the National Health System (RedETS); funded at national level and including all public HTA organizations at national and regional levels. RedETSis focused on the assessment of nondrug health technologies to inform the revision (approval and funding or disinvestment) of the Benefit Portfolio of the Spanish NHS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000205DOI Listing

Disinvestment Activities and Candidates in the Health Technology Assessment Community: An Online Survey.

Int J Technol Assess Health Care 2019 Apr 22:1-6. Epub 2019 Apr 22.

Clinical Research & Drug Assessment Unit,Local Health Authority of Verona - Veneto Region,Verona,Italy.

Objectives: As healthcare decision makers continue to face challenges in health services delivery to their patients, disinvestment programs are being established for a sustainable healthcare system. This study aimed to collect data and information by means of a survey of disinvestment candidates and ongoing disinvestment projects in the health technology assessment (HTA) community.

Methods: An online survey was conducted to collect information on disinvestment candidates and activities from members of the Health Technology Assessment International Disinvestment & Early Awareness Interest Group, the EuroScan International Network and International Network of Agencies for Health Technology Assessment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000229DOI Listing

Addressing Health System Values in Health Technology Assessment: The Use of Evidence-Informed Deliberative Processes.

Int J Technol Assess Health Care 2019 Apr 8:1-3. Epub 2019 Apr 8.

Consultant, Ecorys Nederland B.V.

Health technology assessment (HTA) is increasingly used around the globe to inform resource allocation decisions. Furthermore, the importance of using explicit and transparent criteria for coverage decision making in line with health system values has been acknowledged. However, the values of a health system are often not explicitly taken into account in the HTA process. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000187DOI Listing

Definiendo el valor de las tecnologías sanitarias en Latino-América: desarrollo de marcos de valor para informar la priorización de recursos sanitarios.

Int J Technol Assess Health Care 2019 Jan;35(1):69-74

Hospital Clinic de Barcelona,Barcelona,Spain.

ResumenObjetivosEl reciente desarrollo de marcos de valor responde a una demanda por hacer más explícito e inclusivo el proceso de toma de decisiones sobre asignación de recursos sanitarios. El objetivo del Foro de Políticas en Latino América 2018 de Health Technology Assessment International fue explorar las experiencias internacionales y discutir la potencial aplicación de marcos de valor en la región.MétodosEste manuscrito está basado en un documento base y en las presentaciones y discusiones mantenidas por los miembros del Foro (43 participantes, 12 países) durante el Foro del 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000126DOI Listing
January 2019

Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources.

Int J Technol Assess Health Care 2019 Jan;35(1):64-68

Hospital Clinic de Barcelona,Barcelona,Spain.

Objectives: The recent development of value frameworks to inform healthcare resource allocation responds to a demand to make the decision-making process more inclusive and explicit. The objectives of the 2018 Latin American (LAtam) Health Technology Assessment International (HTAi) Policy Forum were to explore the current international experiences and to discuss the potential application of value frameworks in Latin America.

Methods: A background paper, presentations, and group discussions of Policy Forum members (43 participants, 12 LAtam countries represented) at the 2018 HTAi Policy Forum meeting informed this paper. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000072DOI Listing
January 2019
1 Read

Assessing Data Sources for Medicine Price Studies.

Int J Technol Assess Health Care 2019 Mar 29:1-10. Epub 2019 Mar 29.

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies,Pharmacoeconomics Department,Gesundheit Österreich GmbH (GÖG / Austrian Public Health Institute),Vienna,Austria.

Objectives: There is no established methodology to assess the feasibility of medicine price data sources. Against this backdrop, a framework to guide the selection of most appropriate price data sources for pharmacoeconomic research has been developed.

Methods: A targeted literature review was carried out. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000138DOI Listing

Methods Assessing Sociocultural Aspects of Health Technologies: Results of a Literature Review.

Int J Technol Assess Health Care 2019 Mar 28:1-7. Epub 2019 Mar 28.

Department of Health Services Research,University of Bremen,Bremen,Germany.

Objectives: Social and cultural aspects are rarely assessed in health technology assessments (HTA), despite being part of most HTA definitions. One hypothesis for the reason why they are hardly considered in HTA is that we lack relevant assessment methods. Accordingly, this review aims at providing an overview of methodological approaches to address social and cultural aspects related to health technologies in HTA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000102DOI Listing

Exploring the Application of Cost-Effectiveness Evaluation in the Japanese National Health Insurance System.

Int J Technol Assess Health Care 2019 Mar 21:1-9. Epub 2019 Mar 21.

National Institute of Public Health,Saitama,Japan.

Objectives: Advances in health care due to the development and introduction of new drugs and medical devices have brought considerable benefits to people and patients in terms of upgraded quality of life and extended years of survival. However, some are concerned that the very advancement of health care would increase further the inflation of national healthcare costs. In response to these concerns, Japan's Central Social Insurance Medical Council ("Chuikyo") began in 2012 to examine how cost-effectiveness evaluation might be applied to the national health insurance system, and has been working toward establishing a system for its usage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000060DOI Listing

Cost-Effectiveness of Pain Management Strategies in Advanced Cancer.

Int J Technol Assess Health Care 2019 Mar 15:1-9. Epub 2019 Mar 15.

Academic Unit of Palliative Care,Leeds Institute of Health Sciences, University of Leeds,United Kingdom.

Objectives: Uncontrolled pain in advanced cancer is a common problem and has significant impact on individuals' quality of life and use of healthcare resources. Interventions to help manage pain at the end of life are available, but there is limited economic evidence to support their wider implementation. We conducted a case study economic evaluation of two pain self-management interventions (PainCheck and Tackling Cancer Pain Toolkit [TCPT]) compared with usual care. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000114DOI Listing
March 2019
8 Reads

Toward a Strategy to Involve Patients in Health Technology Assessment in Spain.

Int J Technol Assess Health Care 2019 Mar 14:1-7. Epub 2019 Mar 14.

Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC).

Objectives: The aim of this study was to develop a feasible and effective strategy to involve patients in the Spanish Network of Agencies of Health Technology Assessment (RedETS).

Methods: The framework for patient involvement (PI) in the assessment activities and processes of RedETS were developed through a research project that included: (i) a systematic search of the international literature describing a strategy and/or a methodology linking health technology assessment (HTA) and PI; (ii) a qualitative study through interviews with RedETS members to analyze the perceptions of PI among HTA managers in the Spanish context; (iii) a Delphi consultation with three large platforms of patients, carers and consumer organizations in Spain about their perspectives of PI; (iv) a consensus process with the members of the RedETS Governing Council to define the final strategy.

Results: Three main themes were identified in the literature and Web site review: (i) PI methods for the different HTA phases; (ii) Participant definition and selection; (iii) Resources needed. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462319000096DOI Listing
March 2019
3 Reads

Health Technology Assessment in Malaysia: Past, Present, and Future.

Int J Technol Assess Health Care 2019 Mar 13:1-6. Epub 2019 Mar 13.

Malaysian Health Technology Assessment Section (MaHTAS),Medical Development Division,Ministry of Health Malaysia.

Objectives: The aim of this study was to provide a comprehensive overview of the evolution of health technology assessment (HTA) in Malaysia over the past decade.

Methods: We described the evolution of HTA program in Malaysia based on review of administrative data, publicly available information and quantitative description of impact evaluation.

Results: Health Technology Assessment HTA was formalized in Malaysia in 1995 as a central structure within the Ministry of Health, Malaysia in 1995. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000023DOI Listing

Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore.

Int J Technol Assess Health Care 2019 Mar 11:1-8. Epub 2019 Mar 11.

Agency for Care Effectiveness,Ministry of Health,Singapore.

Objectives: This study was conducted to evaluate the cost-effectiveness of sunitinib versus interferon-alfa for the treatment of advanced and/or metastatic renal cell carcinoma (RCC) in Singapore.

Methods: A partitioned survival model with three health states (progression-free, progressive disease, and death) was developed from a healthcare payer perspective over a 10-year time horizon. Survival curves from the pivotal trial of sunitinib versus interferon-alfa were extrapolated beyond the trial period to estimate the underlying progression-free survival and overall survival parametric distributions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000059DOI Listing
March 2019
4 Reads

Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? an early cost-utility analysis.

Int J Technol Assess Health Care 2019 Mar 4:1-10. Epub 2019 Mar 4.

Nuffield Department of Primary Care Health Sciences,University of Oxford.

Objectives: Patients with chronic obstructive pulmonary disease (COPD) who experience acute exacerbations usually require treatment with oral steroids or antibiotics, depending on the etiology of the exacerbation. Current management is based on clinician's assessment and judgement, which lacks diagnostic accuracy and results in overtreatment. A test to guide these decisions in primary care is in development. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003707DOI Listing
March 2019
2 Reads

Hospital-based Health Technology Assessment in Kazakhstan: 3 years' experience of one unit.

Int J Technol Assess Health Care 2019 Mar 4:1-5. Epub 2019 Mar 4.

Astana Medical University,Kazakhstan.

Objectives: The aim of this study was to describe the development and activities of the Hospital-Based Health Technology Assessment (HB-HTA) Unit in the Hospital of the President's Affairs Administration, one of the first examples of the implementation of HB-HTA into the practice of Kazakhstani hospitals.

Methods: Details of the development of the Unit were obtained from the hospital's administrative records. The Unit's own records were used to describe the reports prepared and the clinical areas that were covered. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003744DOI Listing

Hurdle Poisson Regression Model for Identifying Factors Related to Noncompliance and Waiting Time for Confirmatory Diagnosis in Colorectal Cancer Screening.

Int J Technol Assess Health Care 2019 Mar 1:1-7. Epub 2019 Mar 1.

Department of Health Industry Management,Kainan University,Taoyuan,Taiwan.

Objectives: Population-based colorectal cancer (CRC) screening programs that use a fecal immunochemical test (FIT) are often faced with a noncompliance issue and its subsequent waiting time (WT) for those FIT positives complying with confirmatory diagnosis. We aimed to identify factors associated with both of the correlated problems in the same model.

Methods: A total of 294,469 subjects, either with positive FIT test results or having a family history, collected from 2004 to 2013 were enrolled for analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000047DOI Listing

Adaptive Evolution in Rapid Assessments: A 25-Year Perspective.

Int J Technol Assess Health Care 2019 Feb 28:1-5. Epub 2019 Feb 28.

Institute of Health Economics,Edmonton, AB,Canada.

Objectives: This article retrospectively examines the evolution of rapid assessments (RAs) produced by the Health Technology Assessment (HTA) Program at the Institute of Health Economics over its 25-year relationship with a single requester, the Alberta Health Ministry (AHM).

Methods: The number, types, and methodological attributes of RAs produced over the past 25 years were reviewed. The reasons for developmental changes in RA processes and products over time were charted to document the push-pull tension between AHM needs and the HTA Program's drive to meet those needs while responding to changing methodological benchmarks. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000035DOI Listing
February 2019

Outcomes and Impacts of 10-Year HTA Implementation in Taiwan.

Int J Technol Assess Health Care 2019 Feb 28:1-5. Epub 2019 Feb 28.

Executive Director Office,Center for Drug Evaluation,Taiwan.

Objectives: In 2007, Taiwan began conducting health technology assessments (HTA) to support the National Health Insurance Administration (NHIA) in its reimbursement decisions for drugs, medical devices, and medical services.

Methods: In this study, the development, missions, and procedures of the implementation of HTA in Taiwan are briefly introduced. Moreover, the value of HTA is examined by reviewing the outcomes and impacts of recent HTA-related research projects, which are classified into five categories: (i) pharmaceutical products, (ii) medical procedures, (iii) medical devices, (iv) health policy, and (v) social care. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462319000011DOI Listing
February 2019

Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company.

Int J Technol Assess Health Care 2019 Jan 21;35(1):10-16. Epub 2019 Feb 21.

MORSE - Health Technology Assessment Group, F. Hoffmann-La Roche.

Objectives: Evidence requirements and assessment methods access differ between health technology assessment (HTA) agencies. The HTA Core Model® provides a standardized approach to HTA, targeting evidence sharing and collaboration between participating HTA bodies. It is fit for purpose from an industry perspective and was used by pharmaceutical company Roche to develop a framework for internal assessment of evidence required for market access and coverage/reimbursement ("access evidence"). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003653DOI Listing
January 2019

Quality Assessment of Reporting of Economic Evaluation in Cardiac Sugery: Has it Improved?

Int J Technol Assess Health Care 2019 Jan 12;35(1):45-49. Epub 2019 Feb 12.

Service de Chirurgie Cardiaque,Hôpital Cardiologique Louis Pradel,Université Claude Bernard.

Objectives: Cardiac surgery has seen substantial scientific progress over recent decades. Health economic evaluations have become important tools for decision makers to prioritize scarce health resources. The present study aimed to identify and critically appraise the reporting quality of health economic evaluations conducted in the field of cardiac surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003768DOI Listing
January 2019

Nudging in Neonatology: Practical Wisdom and Accountability for Reasonableness.

Authors:
Michal Stanak

Int J Technol Assess Health Care 2019 Jan 12;35(1):5-9. Epub 2019 Feb 12.

Ludwig Boltzmann Institute for Health Technology Assessment and Department of Philosophy,University of Vienna.

Objectives: The way choice is presented has an impact on decision-making. This is the case also in the context of neonatal intensive care units (NICUs), particularly in the challenging cases that concern the limit of viability. The objective of this article is to examine the role of nudging in the shared decision-making in neonatology and elaborate on the respective moral challenges. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003732DOI Listing
January 2019
1 Read

Early assessment of innovation in a healthcare setting.

Int J Technol Assess Health Care 2019 Jan 12;35(1):17-26. Epub 2019 Feb 12.

Oslo University Hospital,Centre for Connected Care.

Objectives: Early assessment can assist in allocating resources for innovation effectively and produce the most beneficial technology for an institution. The aim of the present study was to identify methods and discuss the analytical approaches applied for the early assessment of innovation in a healthcare setting.

Methods: Knowledge synthesis based on a structured search (using the MEDLINE, Embase, and Cochrane databases) and thematic analysis was conducted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003719DOI Listing
January 2019
7 Reads

How Procurement Judges The Value of Medical Technologies: A Review of Healthcare Tenders.

Int J Technol Assess Health Care 2019 Jan 8;35(1):50-55. Epub 2019 Feb 8.

Institute of Health Policy,Management and Evaluation, University of Toronto.

Objectives: Procurement's important role in healthcare decision making has encouraged criticism and calls for greater collaboration with health technology assessment (HTA), and necessitates detailed analysis of how procurement approaches the decision task.

Methods: We reviewed tender documents that solicit medical technologies for patient care in Canada, focusing on request for proposal (RFP) tenders that assess quality and cost, supplemented by a census of all tender types. We extracted data to assess (i) use of group purchasing organizations (GPOs) as buyers, (ii) evaluation criteria and rubrics, and (iii) contract terms, as indicators of supplier type and market conditions. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003756DOI Listing
January 2019
2 Reads

Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.

Int J Technol Assess Health Care 2019 Jan 7;35(1):56-63. Epub 2019 Feb 7.

ACCU Confederation.

Objectives: Patient involvement in drug evaluation decision making is increasing. The aim of the current study was to develop a multi-criteria decision analysis (MCDA) framework that would enable the inclusion of the patient perspective in the selection of appropriate criteria for MCDAs being used in the value assessments of oncologic drugs.

Methods: A literature review was conducted to identify and define criteria used in drug assessments from patient perspectives. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003641DOI Listing
January 2019
11 Reads

Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.

Int J Technol Assess Health Care 2019 Jan 6;35(1):36-44. Epub 2019 Feb 6.

Department of Economic and Public Health Evaluation,French National Authority for Health (HAS), Saint-Denis La Plaine,France.

Objectives: The aim of this study was to estimate the effectiveness of first-line biologic disease modifying drugs(boDMARDs), and their approved biosimilars (bsDMARDs), compared with conventional (csDMARD) treatment, in terms of ACR (American College of Rheumatology) and EULAR (European League against Rheumatism) responses.

Methods: Systematic literature search, on eight databases to January 2017, sought ACR and EULAR data from randomized controlled trials (RCTs) of boDMARDs / bsDMARDs (in combination with csDMARDs, or monotherapy). Two adult populations: methotrexate (MTX)-naïve patients with severe active RA; and csDMARD-experienced patients with moderate-to-severe active RA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003628DOI Listing
January 2019
6 Reads

What is the impact of physicians in prehospital treatment for patients in need of acute critical care? - An overview of reviews.

Int J Technol Assess Health Care 2019 Jan 6;35(1):27-35. Epub 2019 Feb 6.

DEFACTUM,Department of Public Health and Health Services Research.

Objectives: The aim of this overview was to systematically identify and synthesize existing evidence from systematic reviews on the impact of prehospital physician involvement.

Methods: The Medline, Embase, and Cochrane library were searched from 1 January 2000 to 17 November 2017. We included systematic reviews comparing physician-based with non-physician-based prehospital treatment in patients with one of five critical conditions requiring a rapid response. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003616DOI Listing
January 2019

Selecting digital health technologies for validation and piloting by healthcare providers: a decision-making perspective from ontario.

Int J Technol Assess Health Care 2019 Jan 4;35(1):1-4. Epub 2019 Feb 4.

Thunder Bay Regional Health Research Institute.

Digital health technologies (DHTs) such as health apps are rapidly emerging as a major disruptor of health care. Yet there is no well-established process of decision making for selecting DHTs that are worthy of investing resources in their validation to determine whether they are ready (safe, effective, and not too costly) for health related use. We report here on an Ontario-based initiative to support such decision making. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003720DOI Listing
January 2019

RESPONSE TO ON THE COSTS OF HOME-BASED TELEMEDICINE PROGRAMS: A COMMENT ON MICHAUD ET AL.

Authors:
Tzeyu L Michaud

Int J Technol Assess Health Care 2018 Jan;34(6):594

Center for Reducing Health Disparities, College of Public Health,Department of Health Promotion, College of Public Health, University of Nebraska Medical Center Omaha,

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003677DOI Listing
January 2018
2 Reads

ON THE COSTS OF HOME-BASED TELEMEDICINE PROGRAMS: A COMMENT ON MICHAUD ET AL.

Authors:
Kristian Kidholm

Int J Technol Assess Health Care 2018 Jan;34(6):593

Center for Innovative Medical Technology, Odense University Hospital,Denmark.

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003665DOI Listing
January 2018
2 Reads

SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS - ERRATUM.

Int J Technol Assess Health Care 2018 Jan;34(6):595

Institute for Research in Operative Medicine, Witten/Herdecke University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S026646231800363XDOI Listing
January 2018
1 Read

COMBINING INSTITUTIONAL AND ADMINISTRATIVE DATA TO ASSESS HOSPITAL COSTS FOR PATIENTS RECEIVING VENTRICULAR ASSIST DEVICES.

Int J Technol Assess Health Care 2018 Jan;34(6):555-566

St Vincent's Hospital,Faculty of Health University of Technology

Objectives: The aim of this study was to describe patient level costing methods and develop a database of healthcare resource use and cost in patients with AHF receiving ventricular assist device (VAD) therapy.

Methods: Patient level micro-costing was used to identify documented activity in the years preceding and following VAD implantation, and preceding heart transplant for a cohort of seventy-seven consecutive patients listed for heart transplantation (2009-12). Clinician interviews verified activity, established time resource required for each activity, and added additional undocumented activities. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003586DOI Listing
January 2018
12 Reads

COST-UTILITY ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT IN THAILAND.

Int J Technol Assess Health Care 2018 Dec 18:1-9. Epub 2018 Dec 18.

Department of Pharmacy,Faculty of Pharmacy,Mahidol University.

Objectives: Although interferon beta-1a (IFNß-1a), 1b (IFNß-1b), and fingolimod have been approved as multiple sclerosis (MS) treatments, they have not yet been included on the National List of Essential Medicines (NLEM) formulary in Thailand. This study aimed to evaluate the cost-utility of MS treatments compared with best supportive care (BSC) based on a societal perspective in Thailand.

Methods: A Markov model with cost and health outcomes over a lifetime horizon with a 1-month cycle length was conducted for relapsing-remitting MS (RRMS) patients. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003604DOI Listing
December 2018
7 Reads

COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN.

Int J Technol Assess Health Care 2018 Dec 18:1-8. Epub 2018 Dec 18.

Social Determinants of Health Research Center, Mashhad University of Medical Sciences Non-Communicable Disease Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical

Objectives: This study aimed to assess the cost-effectiveness of ivabradine plus standard of care (SoC) in comparison with current SoC alone from the Iranian payer perspective.

Methods: A cohort-based Markov model was developed to assess the incremental cost-effectiveness ratio (ICER) over a 10-year time horizon in a cohort of 1,000 patients. The baseline transition probabilities between New York Heart Association (NYHA), mortality rate, and hospitalization rate were extracted from the literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003598DOI Listing
December 2018
4 Reads

AGING AND HEALTH TECHNOLOGY ASSESSMENT: AN IDEA WHOSE TIME HAS COME.

Int J Technol Assess Health Care 2018 Jan;34(5):442-446

University of

Objectives: With the increase in technologies to support an aging population, health technology assessment (HTA) of aging-related technologies warrants special consideration. At Health Technology Assessment international (HTAi) 2016 and HTAi 2017, an international panel explored interests in HTA focused on aging.

Methods: Panelists from five countries shared the state of aging and HTA in their countries. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000600DOI Listing
January 2018
23 Reads

WHICH DATABASES SHOULD BE USED TO IDENTIFY STUDIES FOR SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS?

Int J Technol Assess Health Care 2018 Jan 16;34(6):547-554. Epub 2018 Nov 16.

York Health Economics Consortium (YHEC).

Objectives: This study investigated which databases and which combinations of databases should be used to identify economic evaluations (EEs) to inform systematic reviews. It also investigated the characteristics of studies not identified in database searches and evaluated the success of MEDLINE search strategies used within typical reviews in retrieving EEs in MEDLINE.

Methods: A quasi-gold standard (QGS) set of EEs was collected from reviews of EEs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000636DOI Listing
January 2018
2 Reads

REAL-WORLD CLINICAL EVALUATION AND COSTS OF TELEMEDICINE FOR CHRONIC WOUND MANAGEMENT.

Int J Technol Assess Health Care 2018 Jan 29;34(6):567-575. Epub 2018 Oct 29.

Caen University Hospital Center.

Background: Chronic wounds are frequent, affect quality of life, and increase care costs. Telemedicine provides potential for effective wound care management, especially for the monitoring of complex wounds at home.

Objectives: The objective of the present study was to determine the clinical effects and costs of telemedicine for the follow-up of complex chronic wounds from the perspective of the public health insurance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000685DOI Listing
January 2018
24 Reads

HOW BAR CODED MEDICATION ADMINISTRATION TECHNOLOGY AFFECTS THE NURSE-PATIENT RELATIONSHIPS: AN ETHNOGRAPHIC STUDY.

Int J Technol Assess Health Care 2018 Jan 26;34(5):507-513. Epub 2018 Oct 26.

Department of Care Ethics,University of Humanistic Studies.

Objectives: This study aims to assess how care is mediated through technology by analyzing the interaction between nurses, patients, and a Bar Coded Medication Administration (BCMA) system. The objective is to explore how patients experience care through medication technology, with the main focus of our observations and interviews on nurses rather than patients.

Methods: A qualitative ethnographic study was conducted in an orthopedic ward of a Dutch general hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000582DOI Listing
January 2018
1 Read

MULTI-CRITERIA DECISION ANALYSIS AS A DECISION-SUPPORT TOOL FOR DRUG EVALUATION: A PILOT STUDY IN A PHARMACY AND THERAPEUTICS COMMITTEE SETTING.

Int J Technol Assess Health Care 2018 Jan 23;34(5):519-526. Epub 2018 Oct 23.

Department of Pharmacy,Hospital Universitario Virgen Macarena.

Objectives: The aim of this study was to develop and to assess a specific Multi-Criteria Decision Analysis (MCDA) framework to evaluate new drugs in an hospital pharmacy and therapeutics committee (P&TC) setting.

Methods: A pilot criteria framework was developed based on the EVIDEM (Evidence and Value: Impact on DEcisionMaking) framework, together with other relevant criteria, and assessed by a group of P&TC's members. The weighting of included criteria was done using a 5-point weighting technique. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000569DOI Listing
January 2018
13 Reads

SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS.

Int J Technol Assess Health Care 2018 Jan 22;34(6):537-546. Epub 2018 Oct 22.

Institute for Research in Operative Medicine.

Objectives: When making decisions in health care, it is essential to consider economic evidence about an intervention. The objective of this study was to analyze the methods applied for systematic reviews of health economic evaluations (SR-HEs) in HTA and to identify common challenges.

Methods: We manually searched the Web pages of HTA organizations and included HTA-reports published since 2015. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000624DOI Listing
January 2018
20 Reads

IS THE EUNETHTA HTA CORE MODEL® FIT FOR PURPOSE? EVALUATION FROM AN INDUSTRY PERSPECTIVE.

Int J Technol Assess Health Care 2018 Jan 18;34(5):458-463. Epub 2018 Oct 18.

Faculty of Health Sciences,University of Southern Denmark.

Objectives: The HTA Core Model® was developed to improve the transferability of health technology assessment (HTA) between settings. The model has been used by HTA agencies but is also of interest to manufacturers, for improving internal evidence generation and communicating with other HTA stakeholders. To establish if the model is fit for purpose from an industry perspective, the pharmaceutical company Roche, collaborating with the European Network for HTA (EUnetHTA), conducted an assessment of the model. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000594DOI Listing
January 2018
2 Reads

COST, CONTEXT, AND DECISIONS IN HEALTH ECONOMICS AND HEALTH TECHNOLOGY ASSESSMENT.

Authors:
Anthony J Culyer

Int J Technol Assess Health Care 2018 Jan 17;34(5):434-441. Epub 2018 Oct 17.

University of York - Economics & Related

Objectives: This study is an attempt to demystify and clarify the idea of cost in health economics and health technology assessment (HTA).

Methods: Its method draws on standard concepts in economics. Cost is a more elusive concept than is commonly thought and can be particularly elusive in multidisciplinary territory like HTA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000612DOI Listing
January 2018
1 Read

SHARING AND COLLECTING HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT REPORTS INTERNATIONALLY: IS AN EXTENSIVE PARTICIPATION OF STAKEHOLDERS REALISTIC?

Int J Technol Assess Health Care 2018 Jan 16;34(5):527-534. Epub 2018 Oct 16.

Italian National Institute for Health National Center for Health Technology Assessment.

Objectives: The emergence of new medical technologies and budget restrictions has led to a substantial increase in the use of hospital-based health technology assessment (HB-HTA). This qualitative study explores whether there is a possibility and interest to realize the collection and dissemination of HB-HTA reports on an international scale by exploring the opinions from HB-HTA experts.

Methods: A survey was designed and sent to an international group of experts knowledgeable in HB-HTA from eighteen different countries. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000570DOI Listing
January 2018
4 Reads

COST-EFFECTIVENESS OF INTERVENTIONS BASED ON PHYSICAL ACTIVITY IN THE TREATMENT OF CHRONIC CONDITIONS: A SYSTEMATIC LITERATURE REVIEW.

Int J Technol Assess Health Care 2018 Jan 9;34(5):481-497. Epub 2018 Oct 9.

Hospinnomics - PSE - École d'économie de Paris,Assistance publique Hôpitaux de Paris.

Objectives: The aim of this study is to review evidence on the cost-effectiveness of exercise-based interventions in the treatment of chronic conditions a decade after the publication of Roine et al. in 2009 (Roine E, Roine RP, Räsänen P, et al. Int J Technol Assess Health Care. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000533DOI Listing
January 2018
3 Reads

ETHICS IN HEALTH TECHNOLOGY ASSESSMENT: A SYSTEMATIC REVIEW.

Int J Technol Assess Health Care 2018 Jan 9;34(5):447-457. Epub 2018 Oct 9.

Faculté de médecine et des sciences de la santé,Université de Sherbrooke,Sherbrooke.

Objectives: Integration of ethics into health technology assessment (HTA) remains challenging for HTA practitioners. We conducted a systematic review on social and methodological issues related to ethical analysis in HTA. We examined: (1) reasons for integrating ethics (social needs); (2) obstacles to ethical integration; (3) concepts and processes deployed in ethical evaluation (more specifically value judgments) and critical analyses of formal experimentations of ethical evaluation in HTA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000508DOI Listing
January 2018
17 Reads

PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.

Int J Technol Assess Health Care 2018 Jan;34(4):425-433

RTI Health Solutions.

Objectives: Adherence to injectable disease-modifying treatments in patients with multiple sclerosis (MS) impacts outcomes and can be influenced by perceptions of treatment efficacy, side effects, injection frequency, and the duration of injection. This study aimed to quantify preferences for selected attributes of injectable treatments among individuals with MS in the United Kingdom and France.

Methods: Respondents with a self-reported diagnosis of MS completed an online discrete-choice-experiment survey, consisting of a series of treatment-choice questions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190072PMC
January 2018
1 Read

QUALITY ASSURANCE OF REGISTRIES FOR HEALTH TECHNOLOGY ASSESSMENT.

Int J Technol Assess Health Care 2018 Jan;34(4):360-367

National Institute for Health and Care

Objectives: The aim of this study was to identify guidelines and assessment tools used by health technology agencies for quality assurance of registries and investigate the current use of registry data by HTA organizations worldwide.

Methods: As part of a European Network for Health Technology Assessment Joint Action work package, we undertook a literature search and sent a questionnaire to all partner organizations on the work package and all organizations listed in the International Society for Pharmaco-economics and Outcomes Research directory.

Results: We identified thirteen relevant documents relating to quality assurance of registries. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000478DOI Listing
January 2018
17 Reads

DIFFERENTIATION OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES BETWEEN FIVE DISEASE AREAS: RESULTS FROM AN INTERNATIONAL SURVEY OF PATIENTS.

Int J Technol Assess Health Care 2018 Jan 25;34(5):498-506. Epub 2018 Sep 25.

Department of Social Policy,Medical Technology Research Group,LSE Health.

Objectives: Health-related quality of life (HRQoL) data generated by generic, preference-based instruments (i.e., EQ-5D) are highly demanded in health policy decision making, because they allow for direct comparisons of HRQoL outcomes between disease areas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000557DOI Listing
January 2018
3 Reads

EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION.

Int J Technol Assess Health Care 2018 Jan 24;34(5):514-518. Epub 2018 Sep 24.

Department of Health Services Research,CAPHRI Care and Public Health Research Institute,Maastricht University.

Objectives: This study aims to assess participants' views on previous experiences, the current situation and future perspectives for early dialogue between the pharmaceutical industry, a regulatory agency and health technology assessment bodies (HTABs) in Europe.

Methods: Eleven semi-structured interviews were arranged purposively with experienced people from the pharmaceutical industry, the European Medicines Agency, and an expert in Health Economics. The interview questions focused on the value of early dialogue, the challenges faced during the process of early dialogue, the best time to start an early dialogue, the kind of products most suitable for early dialogue, the current situation, and future perspectives for the early dialogue process. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000545DOI Listing
January 2018
2 Reads

QUALITY AND USE OF FREE SMOKING CESSATION APPS FOR SMARTPHONES.

Int J Technol Assess Health Care 2018 Jan 18;34(5):476-480. Epub 2018 Sep 18.

Department of Medical

Objectives: Smartphone Apps are one of the tools available to support patients who wish to quit smoking. Content analysis studies have indicated multiple deficiencies within these Apps including minimal use of evidence-based research and Nicotine Dependence Treatment Provider (NDTP) in App development. The aim of this study was to determine quality and features of smoking cessation Apps available on Android® and iOS® platforms. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000521DOI Listing
January 2018
4 Reads

SUITABILITY OF CURRENT EVALUATION FRAMEWORKS FOR USE IN THE HEALTH TECHNOLOGY ASSESSMENT OF MOBILE MEDICAL APPLICATIONS: A SYSTEMATIC REVIEW.

Int J Technol Assess Health Care 2018 Jan 11;34(5):464-475. Epub 2018 Sep 11.

Adelaide Health Technology (AHTA),School of Public Health, The University of Adelaide.

Objectives: To identify and appraise existing evaluation frameworks for mobile medical applications (MMA) and determine their suitability for use in health technology assessment (HTA) of these technologies.

Methods: Systematic searches were conducted of seven bibliographic databases to identify literature published between 2008 and 2016 on MMA evaluation frameworks. Frameworks were eligible if they were used to evaluate at least one of the HTA domains of effectiveness, safety, and/or cost and cost-effectiveness of an MMA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S026646231800051XDOI Listing
January 2018
1 Read